ATP-competitive inhibition of the BCR::ABL1 tyrosine kinase blocks survival/proliferation signaling (e.g., PI3K/AKT, RAS/MAPK, STAT), causing cell-cycle arrest and apoptosis of BCR::ABL1-positive cells.